neurotherapeutics

neu·ro·ther·a·peu·tics

, neurotherapy (nū'rō-thār'ă-pyū'tiks, -thār'ă-pē),
An older term for the treatment of psychological, psychiatric, and nervous disorders.
References in periodicals archive ?
"Multiple magnetic pulses create a concurrent electrical field on the surface of the gray matter of the cortex, stimulating the brain cells," explains Darin Dougherty, MD, the Director of the Division of Neurotherapeutics at MGH.
The research team's current findings have been detailed in the journal Expert Review of Neurotherapeutics. (ANI)
M2 PHARMA-March 12, 2018-Clinical Data on Aptinyx' NYX-2925 Presented at American Society for Experimental Neurotherapeutics Annual Meeting
He is an Assistant Professor of Neurology and Neurotherapeutics at University of Texas Southwestern, Dallas, TX.
Revealing his idea in the journal NeuroTherapeutics, the researcher suggests that Alzheimer's treatment should combine molecules that protect neurons from plaque build-up with approved therapies like cholinesterase inhibitors, which treat cognition and memory loss.
The US National Institute of Health's Blueprint Neurotherapeutics Network, which has funded the therapy's discovery and development, will continue to provide support and funding through to the completion of Phase I clinical trials.
M2 EQUITYBITES-October 18, 2017-Genisphere signs neurotherapeutics collaboration agreement with Inserm
Olson, PhD RN CNRN, is Associate Professor of Neurology & Neurotherapeutics and Neurosurgery, University of Texas Southwestern, Dallas, TX.
Dr Wheless is a diplomat of the American Board of Pediatrics and the American Board of Psychiatry and Neurology with special qualifications in child neurology, clinical neurophysiology and epilepsy, a fellow of the American Academy of Pediatrics and the American Academy of Neurology as well as member at the Journal of Child Neurology and Neurotherapeutics.
M2 PHARMA-January 30, 2017-Biscayne Forms Neurotherapeutics Business, Closes USD 3m Venture Financing
Sipe, 2005, Expert Review of Neurotherapeutics, 5, pp.
This ten year federal contract was awarded by the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) to support NIH's Drug Manufacturing and Formulation Programme (DMFP), which is a component of the Blueprint Neurotherapeutics Network (BPN).